T. Rowe Price Associates’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95K | Buy |
|
|||||
|
2025
Q1 | $79K | Buy |
|
|||||
|
2024
Q4 | $67K | Sell |
|
|||||
|
2024
Q3 | $132K | Hold |
|
|||||
|
2024
Q2 | $110K | Buy |
|
|||||
|
2024
Q1 | $195K | Hold |
|
|||||
|
2023
Q4 | $55K | Hold |
|
|||||
|
2023
Q3 | $51K | Hold |
|
|||||
|
2023
Q2 | $54K | Hold |
|
|||||
|
2023
Q1 | $61K | Hold |
|
|||||
|
2022
Q4 | $51K | Hold |
|
|||||
|
2022
Q3 | $57K | Hold |
|
|||||
|
2022
Q2 | $80K | Buy |
|
|||||
|
2022
Q1 | $53K | Buy |
|
|||||
|
2021
Q4 | $124K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $9.53M | Sell |
|
|||||
|
2020
Q3 | $7.85M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $20K | Hold |
|
|||||
|
2016
Q4 | $37K | Sell |
|
|||||
|
2016
Q3 | $80K | Hold |
|
|||||
|
2016
Q2 | $81K | Buy |
|